Delivery Order SPE2DB22D1041-SPE2DB24FUCV1

Award Date 7/25/24
Potential Completion Date 7/26/24
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Clomid 50 mg tablets. The contract has a ceiling value of $1,030.08 and a period of performance through July 11, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical distribution company, to provide Clomid 50 mg tablets. The order has a ceiling value of $1,071.21 and a performance period through March 19, 2024. AmerisourceBergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA to supply a comprehensive range of pharmaceutical products and medical supplies to military...
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Clomid 50 mg tablets. The order has a ceiling value of $6,992.87 and was awarded on a firm fixed price basis with a completion date of May 21, 2024. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 held by Amerisourcebergen with the DLA, which serves as the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,118,197 units of Clomid 50 mg tablets. The $1,928.64 firm fixed-price contract has a performance period through February 3, 2025. No set-aside designation was used. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for providing a wide range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4,565,632,416 units of the pharmaceutical product Clomid (clomiphene citrate 50 mg tablets) in 30-count units. The contract has an ultimate completion date of August 30, 2024 and a ceiling value of $1,391.33. It is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the prime contractor, for the provision of 4,563,808,025 units of Clomid 50 mg tablets. The contract has a completion date of March 1, 2024 and a potential value of $1,772.13. Amerisourcebergen Drug Corp, a for-profit organization, is a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The company has...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,545.98 contract is for the delivery of 30-count tablets of the pharmaceutical drug Clomid, a medication commonly prescribed for fertility treatment. The contract has an ultimate completion date of November 7, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is a delivery order placed with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,306.18, is to supply CLOMID 50 MG TABLET UD 30S to the Defense Logistics Agency (DLA), a defense agency. The contract has a firm fixed price pricing type and an ultimate completion date of December 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of CLOMID 50 MG TABLET UD 30S. The one-year contract has a firm fixed price and a ceiling value of $1,142.67. This order is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,563,894,588 units of the medication Clomid 50 mg tablets. The order has a ceiling value of $1,156.62 and a completion date of March 8, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB24FUCV1
    Delivery Order

This is a federal delivery order (SPE2DB22D1041|SPE2DB24FUCV1) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Clomid 50 mg tablets. The contract has a ceiling value of $4,601.64 and a performance period through July 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies from Amerisourcebergen to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 10/27/24, 4:32 AM